The relevant investigative protocol and/or patient note may be attached to your patient's printed or electronic result.

The range of investigative protocols cover conditions associated with:
Clinical Conditions
Abbreviation IP Title
Evaluation of Female Infertility IP231
Evaluation of irregular periods IP232
Hormonal changes during menstrual cycle (overlaid) IP233
Hormonal changes during menstrual cycle (separate) IP234
What is Human Papilloma Virus? IP606
Causes of hyperprolactinaemia IP201
Coagulation Tests
Abbreviation IP Title
Platelet Function Analysis IP402
Risk factors for Venous Thromboembolism IP405
von Willebrand disease IP404
4T scoring system for pretest probability of HIT IP147
Wells Score: Clinical probability of DVT and PE IP148
Drug Screen Interpretation
Abbreviation IP Title
Evaluation of EDDP (methadone metabolite) results IP250
Evaluation of tetrahydrocannabinol (THC) results IP242
Urine drug screening IP241
Evaluation of amphetamine type substances IP243
Evaluation of benzodiazepine results IP245
Evaluation of cocaine results IP246
Evaluation of opiate results IP248
Endocrine Tests
Abbreviation IP Title
Glucose-6-phosphate dehydrogenase (G6PD) deficiency IP271
Evaluation of an elevated serum TSH (> 5.0 mU/L) IP211
Evaluation of a subnormal serum TSH (< 0.3 mU/L) IP212
General Biochemistry
Abbreviation IP Title
Causes of low plasma bicarbonate IP051
Causes of high plasma bicarbonate IP052
Causes of hypercalcaemia IP081
Evaluation of hypercalcaemia IP082
Evaluation of hypocalcaemia IP083
Causes of an elevated CK IP111
Suggested diabetes screening flowchart IP092
Estimate Glomerular Filtration Rate (eGFR) IP061
Investigation of Familial Hypercholesterolaemia IP163
Evaluation of hyperglobulinaemia IP101
Evaluation of hypoglycaemia IP091
Venesection for haemochromatosis IP406
Evaluation of Lactate Dehydrogenase Isoenzymes (LDI) IP504
PBS criteria for lipid-lowering drugs: Patients other than very high risk IP162
PBS criteria for lipid-lowering drugs: Very high risk patients IP161
Cardiac enzyme changes during myocardial infarction IP112
Causes of hypomagnesaemia (Magnesium < 0.7 mmol/L) IP084
Metabolic syndrome IP093
Causes of hyperphosphataemia IP086
Causes of hypophosphataemia IP085
Evaluation of polyuria IP071
Causes of hyperkalaemia IP033
Evaluation of hyperkalaemia IP034
Causes of hypokalaemia IP031
Evaluation of hypokalaemia IP032
Screening for Proteinuria and Chronic Kidney Disease (CKD) IP611
Causes of hyponatraemia IP022
Causes of hypernatraemia IP021
Evaluation of hyperuricaemia IP171
Abbreviation IP Title
Guide to anti-dsDNA and anti-ENA testing IP511
Investigation of coeliac disease IP510
Evaluation of selective IgA deficiency IP506
Evaluation of IgM paraprotein IP505
Evaluation of plasma cell dyscrasias IP507
Allergen specific IgE IP513
Liver Function Tests
Abbreviation IP Title
Evaluation of an isolated serum ALP elevation IP134
Evaluation of serum ALP elevation IP131
Marked serum ALP elevation in child < 5 years old IP133
Causes of an elevated serum GGT IP113
Evaluation of an elevated serum LD IP114
Evaluation of a moderate elevation of aminotransferase levels (ALT and AST) IP130
Predominant hepatocellular pathology IP123
Evaluation of LFT pattern not typical of liver disease IP116
Causes of isolated hyperbilirubinaemia IP121
Evaluation of isolated hyperbilirubinaemia IP122
Evaluation of jaundice (cholestatic) IP125
Evaluation of jaundice (hepatocellular) IP126
Evaluation of localised cholestasis IP124
Evaluation of mixed hepatocellular and cholestatic disease IP115
Abbreviation IP Title
Carbapenem Resistant Enterobacteriaceae (CRE) IP621
Chikungunya virus IP625
Causes of isolated microscopic haematuria IP604
Laboratory diagnosis of dengue infection IP619
Plasmid mediated AmpC production (PAMP) IP615
Pleural effusions IP630
Post-vasectomy testing IP618
Testing for STIs for men who have sex with men IP620
Treatment of Invasive Meningococcal Disease IP613
Treatment of malaria IP622
Treatment of Pneumocystis jiroveci pneumonia IP617
Zika virus IP633
Abbreviation IP Title
Chronic hepatitis B infection IP139
Hepatitis C virus (HCV) Medicare criteria IP612
Management of Helicobacter pylori infection IP607
Serological events in acute Hepatitis A infection relative to ALT peak IP128
Hepatitis A virus (HAV) IP138
Hepatitis B virus reactivation in immunosuppressed patients IP137
Serological profile for acute Hepatitis B and progression to chronic Hepatitis B IP129
Hepatitis B vaccination IP136
Diagnosis of HIV IP512
Mumps IP626
Treatment of Bordetella pertussis IP501
Q fever IP609
Prevaccination Q fever screening IP610
Treatment of syphilis IP608
Warfarin Management
Abbreviation IP Title
Range of INR recommended for specific applications of Warfarin therapy IP400
Guidelines for an elevated INR on Warfarin IP401
Risk factors for bleeding complications of Warfarin therapy IP403
Patient Notes
Abbreviation IP Title
Faecal occult blood testing IP605
What is Barmah Forest virus? IP500
What is blastocystosis? IP600
What is cryptosporidiosis? IP601
What is giardiasis? IP602
What is listeriosis? IP603
What is parvovirus infection? IP502
What is Ross River virus? IP503
What is Norovirus Infection? IP627
What is Adenovirus? IP628
What is Astrovirus? IP629
What is Rotavirus? IP631
What is Sapovirus? IP632